Q BIOMED INC.: 10-Q filed 2015-07-15

Name: Q BIOMED INC.: 10-Q filed 2015-07-15
Creator: Q BIOMED INC.

What Q BIOMED INC. reported in its quarterly report filed 2015-07-15 (fiscal Q2 2015): 18 published measures, 49 facts as tagged in accession 0001393905-15-000357.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-07-15
Fiscal period: fiscal Q2 2015
Accession: 0001393905-15-000357 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Q BIOMED INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-05-31	19,632	USD
At 2014-11-30	12,649	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-05-31	164	USD
At 2014-11-30	1,199	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-05-31	19,468	USD
At 2014-11-30	11,450	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-05-31	715	USD
At 2014-11-30	12,649	USD
At 2014-05-31	12,562	USD
At 2013-11-30	25,000	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-03-01 to 2015-05-31	-3,798	USD	92
2014-12-01 to 2015-05-31	-11,982	USD	182
2014-03-01 to 2014-05-31	-4,569	USD	92
2013-12-01 to 2014-05-31	-12,438	USD	182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2014-12-01 to 2015-05-31	-11,934	USD	182
2013-12-01 to 2014-05-31	-12,438	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-05-31	-50,532	USD
At 2014-11-30	-38,550	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-03-01 to 2015-05-31	3,695,652	shares	92
2014-12-01 to 2015-05-31	3,475,275	shares	182
2014-03-01 to 2014-05-31	2,000,000	shares	92
2013-12-01 to 2014-05-31	2,000,000	shares	182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-03-01 to 2015-05-31	0	USD/shares	92
2014-12-01 to 2015-05-31	0	USD/shares	182
2014-03-01 to 2014-05-31	0	USD/shares	92
2013-12-01 to 2014-05-31	-0.01	USD/shares	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-03-01 to 2015-05-31	-3,798	USD	92
2014-12-01 to 2015-05-31	-11,982	USD	182
2014-03-01 to 2014-05-31	-4,569	USD	92
2013-12-01 to 2014-05-31	-12,438	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-05-31	19,632	USD
At 2014-11-30	12,649	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-05-31	164	USD
At 2014-11-30	1,199	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-05-31	164	USD
At 2014-11-30	1,199	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-03-01 to 2015-05-31	3,798	USD	92
2014-12-01 to 2015-05-31	11,982	USD	182
2014-03-01 to 2014-05-31	4,569	USD	92
2013-12-01 to 2014-05-31	12,438	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-05-31	4,250,000	shares
At 2014-11-30	3,250,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-05-31	65,750	USD
At 2014-11-30	46,750	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-03-01 to 2015-05-31	1,215	USD	92
2014-12-01 to 2015-05-31	3,399	USD	182
2014-03-01 to 2014-05-31	1,569	USD	92
2013-12-01 to 2014-05-31	2,938	USD	182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2014-12-01 to 2015-05-31	-1,035	USD	182

Inspect the source

Entity: Q BIOMED INC. / CIK 0001596062
Captured: 2026-09-22 19:53 UTC
SEC response SHA-256: f89c4e51720d8de34ddffc303f833ea01697bd4742662935a9f3cf09e3e7efbc

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001596062.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))